World Asset Management’s Charles River Laboratories CRL Stock Holding History

World Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$339K	Sell	821 -98	-11%	-$40.7K	0.03%	550
2021 Q2	$340K	Sell	919 -237	-21%	-$79.1K	0.03%	600
2021 Q1	$384K	Sell	1,156 -97	-8%	-$27K	0.03%	559
2020 Q4	$313K	Sell	1,253 -48	-4%	-$11.4K	0.03%	618
2020 Q3	$295K	Sell	1,301 -2	-0.2%	-$415	0.03%	560
2020 Q2	$227K	Buy	+1,303	New	+$208K	0.03%	658
2020 Q1	–	Sell	-1,797	Closed	-$275K	–	967
2019 Q4	$275K	Sell	1,797 -263	-13%	-$36.4K	0.01%	836
2019 Q3	$273K	Buy	2,060 +12	+0.6%	+$1.61K	0.01%	875
2019 Q2	$291K	Buy	2,048 +157	+8%	+$21.3K	0.01%	860
2019 Q1	$275K	Sell	1,891 -25	-1%	-$3.29K	0.01%	885
2018 Q4	$217K	Sell	1,916 -138	-7%	-$17.3K	0.01%	907
2018 Q3	$276K	Buy	2,054 +4	+0.2%	+$494	0.01%	978
2018 Q2	$230K	Sell	2,050 -179	-8%	-$19.4K	0.01%	1097
2018 Q1	$238K	Sell	2,229 -394	-15%	-$42.5K	0.01%	1122
2017 Q4	$287K	Sell	2,623 -191	-7%	-$20.8K	0.01%	1159
2017 Q3	$304K	Buy	2,814 +52	+2%	+$5.34K	0.01%	1123
2017 Q2	$279K	Buy	2,762 +59	+2%	+$5.43K	0.01%	1145
2017 Q1	$243K	Sell	2,703 -172	-6%	-$14.6K	0.01%	1182
2016 Q4	$219K	Sell	2,875 -195	-6%	-$14.8K	0.01%	1183
2016 Q3	$256K	Buy	+3,070	New	+$257K	0.01%	1122
2015 Q2	–	Sell	-3,828	Closed	-$304K	–	1180
2015 Q1	$304K	Sell	3,828 -9	-0.2%	-$664	0.01%	1074
2014 Q4	$244K	Sell	3,837 -598	-13%	-$37.5K	0.01%	1175
2014 Q3	$265K	Sell	4,435 -150	-3%	-$8.58K	0.01%	1182
2014 Q2	$245K	Sell	4,585 -125	-3%	-$6.86K	0.01%	1287
2014 Q1	$284K	Sell	4,710 -114	-2%	-$6.64K	0.01%	1195
2013 Q4	$256K	Sell	4,824 -801	-14%	-$40.2K	0.01%	1265
2013 Q3	$260K	Sell	5,625 -844	-13%	-$38.7K	0.01%	1372
2013 Q2	$265K	Buy	+6,469	New	+$277K	0.01%	1395

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

World Asset Management's CRL Position: Q3 2021 in Review

World Asset Management reduced its Charles River Laboratories (CRL) stake by 11% in Q3 2021, selling an estimated $40.7K and leaving 821 shares worth $339K. The position accounts for 0.03% of the portfolio, ranked #550.

World Asset Management first reported a position in CRL in Q2 2013 and has held it in 28 quarters since. The position peaked at $384K in Q1 2021. 677 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

World Asset Management held 821 shares of Charles River Laboratories worth $339K as of Q3 2021.
World Asset Management sold 98 Charles River Laboratories shares in Q3 2021, an estimated $40.7K.
Charles River Laboratories made up 0.03% of World Asset Management's portfolio in Q3 2021, its #550 holding.
World Asset Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 28 quarters since.
World Asset Management's Charles River Laboratories position peaked at $384K in Q1 2021.
677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.